Iterion Therapeutics Iterion Therapeutics is a clinical-stage biotechnology company developing targeted cancer therapeutics. | ![]() United Therapeutics United Therapeutics is a biotechnology company that develops and manufactures pharmaceutical products for pulmonary arterial hypertension and certain cancers. | ![]() Ayala Pharmaceuticals Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined. | ||
Founding Date | Founding Date 2014 | Founding Date 2004 | Founding Date 1996 | Founding Date 2017 |
Type | Type Private | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Houston, US HQ | Locations Houston, US HQ | Locations Silver Spring, US HQ Durham, US Jacksonville, US Manchester, US Melbourne, US Washington, US | Locations Wilmington, US HQ Rehovot, IL Wilmington, US |
Employees | Employees 17 | Employees 7 | Employees 1,16819% increase | Employees 29 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 15.7 b | Valuation ($) 7.4 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $3.2b (FY, 2025) | Revenue (est.) $692k (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $384.4m (FY, 2025) | Cost of goods $602k (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $2.8b (FY, 2025) | Gross profit $90k (FY, 2022) |
Net income | Net income N/A | Net income N/A | Net income $1.3b (FY, 2025) | Net income ($38m) (FY, 2022) |
Funding | ||||
Latest funding round | Latest funding round $ 2.6m (almost 8 years ago) | Latest funding round $ 865k (almost 7 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 4.4m | Total funding raised $ 8.5m | Total funding raised N/A | Total funding raised $ 47m |

United Therapeutics is a biotechnology company that develops and manufactures pharmaceutical products for pulmonary arterial hypertension and certain cancers.
View company
Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined.
View company